Search for: "Federal, Inc." Results 1201 - 1220 of 57,563
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2012, 10:43 am by Matt Osenga
The Federal Circuit released its long-awaited en banc opinions regarding multi-party infringement, Akamai Techs., Inc. v. [read post]
10 Mar 2008, 9:54 pm
Noonan -- On Friday, the Court of Appeals for the Federal Circuit handed Pfizer a mixed decision on defendant Teva's appeal of a District Court judgment that Teva was liable for infringing a trio of Pfizer patents (U.S. [read post]
25 Mar 2019, 10:15 am by Dustin Weeks
Creative Compounds, LLC, the Federal Circuit reversed the decision of the United States District Court for the Southern District of California, which had held that a series of patents owned by Natural Alternatives International, Inc. [read post]
7 Sep 2020, 4:15 am by IPWatchdog
On August 28, the United States Court of Appeals for the Federal Circuit (CAFC) affirmed the U.S. [read post]
18 Dec 2019, 7:09 am by Eileen McDermott
Government, Arthrex, Inc., and Smith & Nephew, Inc. each submitted petitions for rehearing and/or rehearing en banc asking the full Federal Circuit to reconsider its October 31 ruling in Arthrex v. [read post]
26 Jun 2013, 8:18 am by The Borchardt Law Firm, PLLC
The Form 483 is a notice that informs a company about possible violation(s) of federal regulations that are found by FDA inspectors. [read post]
26 Jun 2013, 8:18 am by The Borchardt Law Firm, PLLC
The Form 483 is a notice that informs a company about possible violation(s) of federal regulations that are found by FDA inspectors. [read post]
26 Jun 2013, 8:18 am by The Borchardt Law Firm, PLLC
The Form 483 is a notice that informs a company about possible violation(s) of federal regulations that are found by FDA inspectors. [read post]
19 Feb 2010, 6:12 am by James R. Copland
As noted in the Trial Lawyers, Inc.: K Street report: Whereas trial lawyers' giving at... [read post]
7 May 2007, 9:09 pm
Noonan -- Although the contours of the Federal Circuit's response to the Supreme Court's obviousness decision in KSR Int'l Co. v. [read post]